Replies to post #84920 on Progressive Care Inc (RXMD)

[angeloh]

I believe the .35 pps price target will be achieved in the next 30-45 days...
Expect a glowing Q1 tomorrow to kick things off towards .20

SeeThru Equity is an unaffiliated corporate research and access company providing unbiased research and analysis to various investor information platforms such as Thompson Reuters, CapitalIQ, etc. It brings company’s visibility to microcap investors, sponsors, and professionals.... Increasing price target to $0.35 for RXMD

“We are increasing our price target for RXMD at this time to $0.35 per share. Shares eclipsed our prior target of $0.10, as the company has continued to grow and execute in a challenging and competitive environment since our last update, with 2016 revenues of $18.3mn and 2017 revenues confirmed at above $20mn by the company in January.